10% Glycolic Solutions Moisturizer

Peter Thomas Roth grew up around his grandparents' Hungarian spa resorts, watching guests emerge from mineral-rich treatments with visibly transformed skin. That childhood exposure to the power of topical chemistry eventually led him to found a skincare brand in 1993 that would become one of the largest privately-owned skincare companies in America — and a champion of putting professional-grade actives in consumer products. The 10% Glycolic Solutions Moisturizer embodies that philosophy: a concentration once reserved for in-office peels, delivered in a daily-use cream.

Ten percent glycolic acid in a leave-on format is not subtle. This is the strongest AHA concentration commonly found in daily-use moisturizers — most competitors cap at 5-8%. Glycolic acid, the smallest AHA molecule at just 76 daltons, penetrates the stratum corneum more deeply than any other alpha-hydroxy acid, dissolving the intercellular bonds that hold dead cells to the surface. The result is accelerated exfoliation that reveals smoother, brighter, more even-toned skin underneath.

The time-released delivery system is what makes 10% glycolic acid wearable as a daily moisturizer. Rather than dumping the full acid concentration onto the skin at once, the formula gradually releases glycolic acid over hours, spreading the exfoliating action across the night and reducing the peak irritation that immediate-release formulations cause. This is the technology that distinguishes a well-formulated high-percentage AHA from a crude acid solution.

Arginine serves as a pH buffer and amino acid humectant, modulating the glycolic acid's acidity to reduce stinging and irritation. It's a clever formulation choice — arginine interacts with glycolic acid at the molecular level to create a partial neutralization that lowers the 'free acid' available at any given moment, while still allowing therapeutic exfoliation to occur over time.

The moisturizing base is respectable. Aloe vera juice sits high in the formula, providing anti-inflammatory and soothing support critical for a high-acid product. Squalane and safflower seed oil deliver emollient moisture. Dimethicone creates a light occlusive seal. Glycerin provides humectant hydration. Together, these prevent the dry, tight, stripped feeling that many potent AHA products cause.

Retinyl palmitate and ascorbyl palmitate (vitamins A and E derivatives) add antioxidant support and mild additional anti-aging action. While retinyl palmitate is a weak retinoid compared to retinol or tretinoin, its inclusion alongside the glycolic acid provides a gentle collagen-stimulating complement without the irritation of layering a stronger retinoid over a 10% AHA.

The fragrance-free formulation is appreciated in a product this active. At 10% glycolic acid, the skin barrier is being deliberately compromised for therapeutic benefit — adding fragrance allergens on top would be irresponsible. Peter Thomas Roth made the right call here, letting the acid work without adding unnecessary irritation.

The initial experience involves a mild tingling that glycolic acid veterans will recognize — a gentle warmth that tells you the acid is active. New users should absolutely start every other night and build tolerance over two weeks. Mild peeling during the first week is normal and expected. By week three, most skin types adjust, and the benefits begin compounding: smoother texture, brighter tone, visibly refined pores, and gradually diminishing fine lines.

The phospholipids in the formula serve as delivery vehicles for fat-soluble actives, potentially enhancing the penetration of retinyl palmitate and squalane into the skin. This is a sophisticated formulation detail that reflects the clinical expertise behind the product.

Results build gradually but visibly. The first week brings a subtle brightening — the 'glycolic glow' that comes from removing the dull surface layer of dead cells. By week four, fine lines begin softening and pore texture refines. At the eight-week mark, hyperpigmentation and age spots show measurable fading as the accelerated cell turnover replaces pigmented cells with fresh ones. At twelve weeks, the cumulative effects create what many users describe as 'my skin but better' — a clarity and smoothness that looks natural rather than treated.

The product's discontinuation is a genuine loss for the glycolic acid community. Over its roughly two-decade run, it built a loyal following among users who appreciated a potent, no-nonsense AHA treatment from a brand with clinical credibility. Finding a direct replacement at the same concentration and in the same moisturizer format isn't straightforward — most brands have moved toward lower concentrations or serum formats.

At $45 for 2.2 ounces, the value was moderate for a clinical-grade AHA treatment. The tube lasted three to four months with nightly use. Compared to professional glycolic peels ($100-200 per session), a potent leave-on AHA at this price represented significant savings for comparable long-term results.

For anyone who can still find this product, it remains one of the most effective OTC glycolic acid treatments ever formulated. For those who can't, the market gap it leaves — a 10% glycolic acid leave-on moisturizer with time-release technology and good supporting ingredients — is worth filling. Someone should.

For glycolic acid devotees who can still find it, the Peter Thomas Roth 10% Glycolic Solutions Moisturizer remains a benchmark for what a clinical AHA moisturizer can achieve. Its legacy is the proof that professional-grade concentrations can work safely and effectively in daily home use — a conviction that Peter Thomas Roth has championed since day one.

Formula

The Science

Glycolic acid at 10% represents a potent leave-on AHA concentration with extensive clinical validation. Research published in the Journal of the American Academy of Dermatology (1996) by Ditre et al. demonstrated that glycolic acid at 8-15% concentrations significantly increased epidermal thickness, dermal collagen density, and glycosaminoglycan content after 6 months of daily application. The mechanism involves disruption of corneodesmosomes in the stratum corneum, accelerating desquamation and stimulating the underlying epidermis to produce new cells.

The time-released delivery mechanism used in this formula — likely based on cyclodextrin encapsulation (cyclodextrin is listed in the ingredients) — creates a gradual release profile that maintains therapeutic AHA levels over hours rather than delivering a bolus dose. Research in the International Journal of Pharmaceutics has demonstrated that cyclodextrin complexes with AHAs reduce peak skin concentration while extending the duration of acid activity, improving both tolerability and cumulative efficacy.

Arginine's role as a pH modulator is supported by formulation chemistry research showing that amino acid buffers can maintain glycolic acid's exfoliating activity while reducing the 'free acid' concentration responsible for stinging and irritation. This allows a 10% total glycolic acid formula to behave more like a 6-7% free acid formula in terms of tolerability, while maintaining a higher total acid reservoir for sustained release.

Dermatologist Perspective

Board-certified dermatologists view 10% glycolic acid as an effective concentration for treating photoaging, melasma, and textural irregularities. Dermatologists note that the time-release and arginine buffering in this formula make it more tolerable than an unbuffered 10% solution, though they still advise gradual introduction and mandatory daily sunscreen. The discontinued status is noted as a loss — dermatologists sometimes struggle to find well-formulated, high-percentage glycolic acid moisturizers to recommend. Patients are advised to use remaining stock within the recommended shelf life.

Guidance

Peter Thomas Roth has been a champion of glycolic acid since the brand's early days in the 1990s, when AHAs were revolutionizing anti-aging skincare. This 10% moisturizer was one of the brand's signature products for over two decades — a testament to the founder's belief that professional-grade concentrations belong in home skincare. While now discontinued, it remains a reference point for clinical glycolic acid moisturizers.

About Peter Thomas Roth Established Brand (5–20 years)

Peter Thomas Roth was founded in 1993 by its Hungarian-born namesake, inspired by his grandparents' spa resorts. The brand remains one of the few privately-owned luxury skincare companies, available at Sephora, Ulta, and high-end spas globally. Known for potent, clinical-grade formulations.

Brand founded: 1993 · Product launched: 2003

Myth vs. Reality

Myth

10% glycolic acid is too strong for home use

Reality

While 10% is at the higher end of OTC concentrations, it's well within the safe range for leave-on products when properly formulated with pH adjustment and buffering agents. This formula uses arginine as a buffer and time-release technology to moderate the acid's impact. Professional peels use 20-70% concentrations.

Myth

Glycolic acid thins the skin

Reality

Glycolic acid removes dead cells from the stratum corneum (which is constantly being replaced), but it actually thickens the living epidermis and dermis by stimulating collagen production. Regular use results in thicker, healthier skin — the opposite of the 'thinning' myth.

FAQ

Common Praise

"Noticeably smoother skin texture within days"

"Effective at reducing fine lines and dullness"

"Not excessively drying for a 10% AHA"

"Gives skin a healthy glow"

Common Complaints

"Can cause redness and irritation on sensitive skin"

"Some users saw no improvement after weeks of use"

"May not be moisturizing enough for dry skin types"

"Now discontinued — limited availability"

Notable Endorsements

Peter Thomas Roth's long-running glycolic productClinical-grade glycolic concentration

Appears In

best exfoliant for aging best exfoliant for texture best exfoliant for dullness best exfoliant for dark spots

Related Conditions

aging texture dullness hyperpigmentation dark spots

Related Ingredients

glycolic acid squalane aloe vera retinyl palmitate vitamin e